We draw your attention, therefore, to the supplement to this issue. A group of nationally recognized experts in breast cancer convened in Tampa, Fla, in late February 1997. They defined the key issues surrounding systemic therapy for breast cancer, reviewed the latest information on each issue, and then described the implications for both clinical research and clinical care. The taxanes, as well as other new and promising drugs, were reviewed. The edited deliberations of this outstanding group constitute the content of the supplement.
Several developments are pertinent to enhanced care.
We hope that you both enjoy and benefit from reading this supplement. These sources should be used for informational purposes only. If you have a health-related problem, please consult a physician.